Skip to main content

How is Bendeka different to Treanda?

Medically reviewed by Carmen Pope, BPharm. Last updated on June 6, 2024.

Official Answer by Drugs.com

Although Bendeka and Treanda both contain bendamustine hydrochloride, there are two main differences between them.

The first difference is that it takes less time to administer the same dosage of Bendeka compared to Treanda.

The second difference is that Bendeka is compatible with polycarbonate or acrylonitrile-butadiene-styrene (ABS)-containing infusion equipment, and Treanda injection is not.

Another difference concerns the confusion that exists by having two types of Treanda formulations available: Treanda Injection and Treanda for Injection which is a powder that requires mixing with sterile water before diluting.

The concentration of bendamustine hydrochloride also differs in these preparations.

Treanda injection and Treanda for injection should not be mixed or combined.

In 2016, Teva replaced Treanda with Bendeka, although Treanda is still available through Cephalon, a subsidiary company of Teva.

Related questions

Bendeka Vs Treanda: Similarities

There are many similarities between Bendeka and Treanda:

References

Read next

How will I feel after a Rituxan infusion?

After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Common side effects include nausea, infusion-related reactions, and feeling tired. Continue reading

How long does it take for Rituxan to work?

Patients treated with Rituxan may notice an early response within 7-8 weeks of treatment. Most rheumatoid arthritis patients will notice some improvement in their symptoms, such as improvement in their levels of pain and inflammation, within 16 weeks of starting treatment with Rituxan. Continue reading

What are CHOP and R-CHOP chemotherapy regimens?

CHOP and R-CHOP are two chemotherapy regimens. CHOP contains cyclophosphamide, doxorubicin, vincristine, and prednisone, while R-CHOP adds rituximab. R-CHOP is the standard treatment for most patients with B-cell non-Hodgkin lymphomas, especially DLBCL, due to its superior efficacy.

Continue reading

See also:

Related medical questions

Drug information

Related support groups